I am Yiran (Eric) Huo, a PhD student in Pharmaceutical Sciences at the University of Pittsburgh School of Pharmacy. I received my B.S. in Pharmaceutical Sciences from Peking University School of Pharmaceutical Sciences and my master’s degree from the University of Michigan College of Pharmacy. My current research focuses on ultrasound-responsive nanomedicine and lipid nanoparticles (LNPs). Nanomedicine is one of the most rapidly advancing areas in modern drug delivery, and stimuli-responsive systems offer the potential to achieve more precise and controllable drug release. By integrating responsive materials into nanoscale delivery systems, I aim to improve therapeutic efficacy while minimizing systemic toxicity. During my master’s training, I received a Rackham Graduate Student Research Grant. My previous research includes a third-author publication in the International Journal of Pharmaceutics focused on reverse engineering complex drug products, as well as a first-author manuscript currently under review at ACS Nano investigating heterogeneity within LNP formulations. I believe nanomedicine will play an increasingly important role in the future of drug delivery and enable new therapeutic approaches for diseases that remain difficult to treat. In the future, I hope to pursue an academic career studying drug delivery mechanisms, developing new biomaterials, and applying advanced imaging technologies to better understand nanomedicines and their interactions with biological systems. Outside the lab, I enjoy urban exploration, particularly discovering interesting architecture and historic sites. To me, exploring unfamiliar places is similar to scientific research: both involve curiosity, uncertainty, and the possibility of unexpected discoveries.
Education & Training
B.S. in Pharmaceutical Sciences, M.S. in Pharmaceutical Sciences
My research focuses on nanomedicine, particularly ultrasound-responsive drug delivery systems and lipid nanoparticles (LNPs). I am interested in understanding how the physicochemical properties and structural heterogeneity of nanoparticles influence their biological performance, as well as developing stimuli-responsive materials that enable precise and controllable drug release. My research aims to improve therapeutic efficacy while reducing systemic toxicity through better control of where, when, and how drugs are delivered.
1. Li, J.; Wang, K.; Lu, Z.; Huo, Y. et al; Schwendeman, A. Characterization of Crinone®: Progesterone Vaginal Gel. International Journal of Pharmaceutics 2025, 684, 126184.
2. Mei, L.*; Huo, Y.*; et al. Schwendeman, A. Asymmetrical Flow Field-Flow Fractionation of mRNA-Loaded Lipid Nanoparticle Fractions with Distinct Physicochemical Properties and mRNA Delivery Abilities. ACS Nano, under peer review.
Rackham Graduate Student Research Grant, Rackham Graduate School, University of Michigan, 2025